[Federal Register Volume 64, Number 223 (Friday, November 19, 1999)]
[Pages 63324-63325]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-30192]



Food and Drug Administration

Nonclinical Studies Subcommittee of the Advisory Committee for 
Pharmaceutical Science; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Nonclinical Studies Subcommittee of the Advisory 
Committee for Pharmaceutical Science
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on December 14, 1999, 8:30 
a.m. to 5:30 p.m.
    Location: Holiday Inn, The Ballrooms, Two Montgomery Village Ave., 
Gaithersburg, MD.
    Contact Person: Kimberly L. Topper at Topperk@cder.fda.gov or Angie 
Whitacre at Whitacrea@cder.fda.gov, Center for Drug Evaluation and 
Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-7001, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12539. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: The subcommittee will discuss collaborative approaches to 
scientific research issues of common interest to the pharmaceutical 
industry, universities, the public, and FDA. Specific areas of focus 
will be in the nonclinical studies areas of: (1) Interspecies 
biomarkers of toxicity, (2) high-resolution magnetic imaging, (3) 
positron emission tomography imaging, and (4) methods to facilitate 
early human assessments.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by December 9, 
1999. Oral presentations from the public will be scheduled between 
approximately 1 p.m. to 2 p.m. Time allotted for each presentation may 
be limited. Those desiring to make formal oral presentations should 
notify the contact person before December 9, 1999, and

[[Page 63325]]

submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: November 10, 1999.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 99-30192 Filed 11-18-99; 8:45 am]